TY - JOUR
T1 - Erratum
T2 - Clinical and histopathological analyses of VEGF receptors peptide vaccine in patients with primary glioblastoma-a case series (BMC Cancer (2020) 20 (196) DOI: 10.1186/s12885-020-6589-x)
AU - Tamura, Ryota
AU - Morimoto, Yukina
AU - Kosugi, Kenzo
AU - Sato, Mizuto
AU - Oishi, Yumiko
AU - Ueda, Ryo
AU - Kikuchi, Ryogo
AU - Nagashima, Hideaki
AU - Hikichi, Tetsuro
AU - Noji, Shinobu
AU - Kawakami, Yutaka
AU - Sasaki, Hikaru
AU - Yoshida, Kazunari
AU - Toda, Masahiro
N1 - Publisher Copyright:
© 2020 The Author(s).
PY - 2020/4/14
Y1 - 2020/4/14
N2 - Following publication of the original article [1], the authors reported an error in the author group. It was reported that Tetsuro Hikichi was missing and the corrected author group is as follows: Ryota Tamura1, Yukina Morimoto1, Kenzo Kosugi1, Mizuto Sato1, Yumiko Oishi1, Ryo Ueda1, Ryogo Kikuchi2, Hideaki Nagashima1, Tetsuro Hikichi4, Shinobu Noji3, Yutaka Kawakami3, Hikaru Sasaki1, Kazunari Yoshida1 and Masahiro Toda1*The competing interests statement has been updated to: TH is an employee of OncoTherapy Science, Inc. The original article [1] has been corrected.
AB - Following publication of the original article [1], the authors reported an error in the author group. It was reported that Tetsuro Hikichi was missing and the corrected author group is as follows: Ryota Tamura1, Yukina Morimoto1, Kenzo Kosugi1, Mizuto Sato1, Yumiko Oishi1, Ryo Ueda1, Ryogo Kikuchi2, Hideaki Nagashima1, Tetsuro Hikichi4, Shinobu Noji3, Yutaka Kawakami3, Hikaru Sasaki1, Kazunari Yoshida1 and Masahiro Toda1*The competing interests statement has been updated to: TH is an employee of OncoTherapy Science, Inc. The original article [1] has been corrected.
UR - http://www.scopus.com/inward/record.url?scp=85083418079&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85083418079&partnerID=8YFLogxK
U2 - 10.1186/s12885-020-06783-8
DO - 10.1186/s12885-020-06783-8
M3 - Comment/debate
C2 - 32290821
AN - SCOPUS:85083418079
SN - 1471-2407
VL - 20
JO - BMC Cancer
JF - BMC Cancer
IS - 1
M1 - 301
ER -